JP2009531441A5 - - Google Patents

Download PDF

Info

Publication number
JP2009531441A5
JP2009531441A5 JP2009502946A JP2009502946A JP2009531441A5 JP 2009531441 A5 JP2009531441 A5 JP 2009531441A5 JP 2009502946 A JP2009502946 A JP 2009502946A JP 2009502946 A JP2009502946 A JP 2009502946A JP 2009531441 A5 JP2009531441 A5 JP 2009531441A5
Authority
JP
Japan
Prior art keywords
formula
compound
salt
composition
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009502946A
Other languages
English (en)
Japanese (ja)
Other versions
JP5430395B2 (ja
JP2009531441A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/007564 external-priority patent/WO2007126812A2/en
Publication of JP2009531441A publication Critical patent/JP2009531441A/ja
Publication of JP2009531441A5 publication Critical patent/JP2009531441A5/ja
Application granted granted Critical
Publication of JP5430395B2 publication Critical patent/JP5430395B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009502946A 2006-03-29 2007-03-29 Hivプロテアーゼインヒビターの調製方法 Active JP5430395B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US78712606P 2006-03-29 2006-03-29
US60/787,126 2006-03-29
PCT/US2007/007564 WO2007126812A2 (en) 2006-03-29 2007-03-29 Process for preparation of hiv protease inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012271186A Division JP2013082717A (ja) 2006-03-29 2012-12-12 Hivプロテアーゼインヒビターの調製方法

Publications (3)

Publication Number Publication Date
JP2009531441A JP2009531441A (ja) 2009-09-03
JP2009531441A5 true JP2009531441A5 (enExample) 2010-05-20
JP5430395B2 JP5430395B2 (ja) 2014-02-26

Family

ID=38323963

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009502946A Active JP5430395B2 (ja) 2006-03-29 2007-03-29 Hivプロテアーゼインヒビターの調製方法
JP2012271186A Withdrawn JP2013082717A (ja) 2006-03-29 2012-12-12 Hivプロテアーゼインヒビターの調製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012271186A Withdrawn JP2013082717A (ja) 2006-03-29 2012-12-12 Hivプロテアーゼインヒビターの調製方法

Country Status (24)

Country Link
US (4) US20110065631A1 (enExample)
EP (2) EP2570416B1 (enExample)
JP (2) JP5430395B2 (enExample)
KR (2) KR101429300B1 (enExample)
CN (2) CN102516259B (enExample)
AP (2) AP2013006690A0 (enExample)
AU (1) AU2007245194B2 (enExample)
BR (1) BRPI0710199A2 (enExample)
CA (1) CA2647316C (enExample)
DK (1) DK1999133T3 (enExample)
EA (2) EA016140B1 (enExample)
ES (2) ES2572001T3 (enExample)
HR (2) HRP20140626A2 (enExample)
IL (2) IL194122A (enExample)
MX (1) MX2008012398A (enExample)
NO (2) NO342102B1 (enExample)
NZ (2) NZ596074A (enExample)
PL (1) PL1999133T3 (enExample)
PT (1) PT1999133E (enExample)
SG (1) SG170794A1 (enExample)
SI (1) SI1999133T1 (enExample)
UA (1) UA97241C2 (enExample)
WO (1) WO2007126812A2 (enExample)
ZA (1) ZA200808046B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
PL2528923T3 (pl) 2010-01-28 2015-01-30 Mapi Pharma Ltd Sposób wytwarzania darunawiru i pochodnych darunawiru
CN102190638A (zh) * 2010-03-16 2011-09-21 中国科学院上海药物研究所 联芳基醇二胺类化合物、其药物组合物、制备方法及应用
CN102584748B (zh) * 2011-01-13 2015-02-11 浙江九洲药业股份有限公司 夫沙那韦中间体的制备方法
EP2702045B1 (en) * 2011-04-26 2017-10-18 Mylan Laboratories Ltd. Novel process for the preparation of etravirine
ES2661705T3 (es) 2011-10-07 2018-04-03 Gilead Sciences, Inc. Métodos para la preparación de análogos de nucleótidos antivirales
EP2634180A1 (en) 2012-03-01 2013-09-04 Lonza Ltd. Enzymatic process for the preparation of butyrolactones
CN103664976B (zh) * 2013-12-12 2015-11-04 惠州市莱佛士制药技术有限公司 一种顺式六氢呋喃并[2,3-b]呋喃-3-醇的制备方法
ES2802376T3 (es) 2014-02-12 2021-01-19 Firmenich Incorporated Procedimiento mejorado para la síntesis de 1-bencil-3-(1-(isoxazol-4-ilmetil)-1h-pirazol-4-il)imidazolidin-2,4-dionas sustituidas
WO2016106050A1 (en) 2014-12-26 2016-06-30 Emory University N4-hydroxycytidine and derivatives and anti-viral uses related thereto
JP6435907B2 (ja) * 2015-02-16 2018-12-12 住友化学株式会社 ヘキサヒドロフロフラノール誘導体の製造方法
CN108610227B (zh) * 2016-12-10 2021-02-09 中国科学院大连化学物理研究所 一种制备双环芳香化合物的方法
RU2020116571A (ru) 2017-12-07 2021-11-22 Эмори Юниверсити N4-гидроксицитидин и производные и связанные с этим противовирусные применения
MX2021008751A (es) 2019-01-25 2021-11-12 Univ Brown Composiciones y metodos para tratar, prevenir o revertir la inflamacion y los trastornos asociados a la edad.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994026749A1 (en) * 1993-05-14 1994-11-24 Merck & Co., Inc. Hiv protease inhibitors
AU1369001A (en) * 1995-12-13 2001-03-22 Abbott Laboratories Retroviral protease inhibiting compounds
ATE401298T1 (de) 1999-12-23 2008-08-15 Ampac Fine Chemicals Llc Verbessertes verfahren zur herstellung von 2s,3s- n-isobutyl-n-(2-hydroxy-3-amino-4-phenylbutyl)- - nitrobenzenesulfonylamid hydrochlorid und anderen derivaten von 2-hydroxy-1,3-diamin
WO2002060905A2 (en) * 2000-10-24 2002-08-08 Glaxo Group Ltd Process for preparing intermediates of hiv protease inhibitors
EP1436884A2 (en) 2001-07-20 2004-07-14 Koninklijke Philips Electronics N.V. Oscillating circuit, converter with such oscillating circuit, and preconditioner with such converter
TW200408645A (en) * 2002-04-26 2004-06-01 Gilead Sciences Inc Non nucleoside reverse transcriptase inhibitors
US20050239054A1 (en) * 2002-04-26 2005-10-27 Arimilli Murty N Method and compositions for identifying anti-HIV therapeutic compounds
WO2005042773A1 (en) * 2003-10-24 2005-05-12 Gilead Sciences, Inc. Methods and compositions for identifying therapeutic compounds

Similar Documents

Publication Publication Date Title
US11267801B2 (en) Therapeutic compounds
JP7745892B2 (ja) N4-ヒドロキシシチジンおよび誘導体ならびにそれらに関連する抗ウイルス用途
AU2020323429B2 (en) Urea compound for antagonizing LPA1 receptor
JP2023535365A5 (enExample)
US20080004242A1 (en) Process for preparation of HIV protease inhibitors
JP2023543059A (ja) 架橋三環式カルバモイルピリドン化合物及びその使用
WO2024108673A1 (en) Triazine derivatives and methods of use thereof
JP2025515833A5 (enExample)
TW200835693A (en) Preparation and utility of non-nucleoside reverse transcriptase inhibitors
JP2005516898A5 (enExample)
TW200533358A (en) Nucleoside phosphonate derivatives useful in the treatment of hiv infections
JP2004528311A5 (enExample)
WO2024009120A1 (en) Triazine derivatives and methods of use thereof
US20240360163A1 (en) Nucleoside Prodrugs and Uses Related Thereto
CN112334130A (zh) Rsv复制抑制剂及其应用
Sozanschi Benzyltetrahydroisoquinoline and bis-benzyltetrahydroisoquinoline alkaloids as anti-parasitic agents
HK40043125B (en) Pyridine derivatives and their use for treating hiv infection
HK40043125A (en) Pyridine derivatives and their use for treating hiv infection
HK40032666B (en) Pyridine derivatives and their use for treating hiv infection
JP2024525880A (ja) 置換三環式アミドおよびその類似体の合成法
HK40032666A (en) Pyridine derivatives and their use for treating hiv infection